Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
{{CMG}}{{APM}}{{AE}}{{CK}} | {{CMG}}{{APM}}{{AE}}{{CK}} | ||
==Overview== | ==Overview== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461" /> | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461">{{cite journal| author=Mahr A, Guillevin L, Poissonnet M, Aymé S| title=Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 1 | pages= 92-9 | pmid=14872461 | doi=10.1002/art.20077 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14872461 }} </ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals.<ref name="pmid15073927">{{cite journal |vauthors=Martin RM, Wilton LV, Mann RD |title=Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies |journal=Pharmacoepidemiol Drug Saf |volume=8 |issue=3 |pages=179–89 |date=May 1999 |pmid=15073927 |doi=10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.0.CO;2-K |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
The incidence of Eosinophilic granulomatosis with polyangiitis range from | The incidence of Eosinophilic granulomatosis with polyangiitis range from 2.5 to 16.6 per 100,000 individuals.<ref name="pmid11926627">{{cite journal |vauthors=Loughlin JE, Cole JA, Rothman KJ, Johnson ES |title=Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients |journal=Ann. Allergy Asthma Immunol. |volume=88 |issue=3 |pages=319–25 |date=March 2002 |pmid=11926627 |doi=10.1016/S1081-1206(10)62015-7 |url=}}</ref> | ||
==Demographics== | ==Demographics== | ||
===Age=== | ===Age=== |
Revision as of 19:39, 3 April 2018
Churg-Strauss syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Churg-Strauss syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
Churg-Strauss syndrome epidemiology and demographics in the news |
Blogs on Churg-Strauss syndrome epidemiology and demographics |
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals.[2]
Incidence
The incidence of Eosinophilic granulomatosis with polyangiitis range from 2.5 to 16.6 per 100,000 individuals.[3]
Demographics
Age
The mean age at diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.
Gender
In general, there is no gender predilection to Eosinophilic granulomatosis with polyangiitis in western nations. In Japan, female predominance has been noted.[4]
Race
In general, there is no racial predominance to eosinophilic granulomatosis with polyangiitis.
References
- ↑ Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
- ↑ Martin RM, Wilton LV, Mann RD (May 1999). "Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies". Pharmacoepidemiol Drug Saf. 8 (3): 179–89. doi:10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.0.CO;2-K. PMID 15073927.
- ↑ Loughlin JE, Cole JA, Rothman KJ, Johnson ES (March 2002). "Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients". Ann. Allergy Asthma Immunol. 88 (3): 319–25. doi:10.1016/S1081-1206(10)62015-7. PMID 11926627.
- ↑ Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H (July 2014). "A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan". Mod Rheumatol. 24 (4): 640–4. doi:10.3109/14397595.2013.857582. PMID 24289197.